Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001512386 | SCV001719795 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002495788 | SCV002798866 | benign | Sucrase-isomaltase deficiency | 2021-07-20 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003987871 | SCV004803247 | benign | not specified | 2024-01-12 | criteria provided, single submitter | clinical testing | Variant summary: SI c.5198-13dupT alters a non-conserved nucleotide located at a position not widely known to affect splicing. Consensus agreement among computation tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.0025 in 243652 control chromosomes in the gnomAD database, including 2 homozygotes. To our knowledge, no occurrence of c.5198-13dupT in individuals affected with Sucrase-Isomaltase Deficiency and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 1165342, Benign). Based on the evidence outlined above, the variant was classified as benign. |